Related Experiment Video
Updated: Jun 7, 2026
05:58
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
"MitoTea": Geranium robertianum L. decoctions decrease blood glucose levels and improve liver mitochondrial oxidative
Fernanda M Ferreira1, Francisco Peixoto, Elsa Nunes
1Department of Environment, Agricultural College of Coimbra - Polytechnic Institute of Coimbra, Bencanta, Portugal. fmlferreira@gmail.com
Acta Biochimica Polonica
|November 4, 2010
Summary
Geranium robertianum (herb Robert) leaf decoctions reduced blood glucose in type 2 diabetes rats. The treatment also enhanced liver mitochondrial respiration and oxidative phosphorylation efficiency.
Area of Science:
- Phytochemistry
- Pharmacology
- Mitochondrial Biology
Background:
- Plant-derived compounds show potential for managing type 2 diabetes mellitus complications.
- Geranium robertianum L. (herb Robert) is a plant with potential pharmacological properties.
Purpose of the Study:
- To investigate the effects of Geranium robertianum leaf decoctions on type 2 diabetes in Goto-Kakizaki (GK) rats.
- To assess the impact of herb Robert on glucose levels and liver mitochondrial function.
Main Methods:
- Oral administration of G. robertianum leaf decoctions to GK rats over four weeks.
- Measurement of plasma glucose levels.
- Evaluation of liver mitochondrial respiratory parameters (state 3, state 4, FCCP-stimulated respiration) and oxidative phosphorylation efficiency.
Main Results:
- Oral administration of G. robertianum lowered plasma glucose levels in diabetic rats.
- Treatment with G. robertianum extracts improved liver mitochondrial respiratory parameters.
- Increased oxidative phosphorylation efficiency was observed in treated rats.
Conclusions:
- Geranium robertianum leaf decoctions demonstrate a hypoglycemic effect in type 2 diabetes.
- Herb Robert treatment positively impacts liver mitochondrial function and energy production in diabetes.
- G. robertianum shows promise as a natural therapeutic agent for type 2 diabetes complications.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...